Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of DNA will rise by +15.54% over the next 2 Weeks and hit $9.64 by Tuesday, May 26, 2026. In that time frame, DNA's share price is expected to range between $8.89 and $10.38.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 26, 2026 | 8.89 | 9.64 | 10.38 |
| May 25, 2026 | 8.68 | 9.43 | 10.17 |
| May 22, 2026 | 8.40 | 9.15 | 9.97 |
| May 21, 2026 | 8.59 | 9.38 | 10.07 |
| May 20, 2026 | 8.55 | 9.36 | 10.09 |
| May 19, 2026 | 8.38 | 9.12 | 9.91 |
| May 18, 2026 | 8.20 | 8.92 | 9.67 |
| May 15, 2026 | 7.86 | 8.64 | 9.47 |
| May 14, 2026 | 8.08 | 8.87 | 9.65 |
| May 13, 2026 | 8.06 | 8.85 | 9.66 |
DNA shares rose +2.76% in Wednesday, May 13, 2026's trading session, rising from a previous close of $8.34 to move at $8.57. The stock demonstrated notable intraday movement (see DNA's key stats for a full breakdown), fluctuating between $8.12 and $8.59, a +5.79% trading range. While recent weeks have seen some volatility, DNA has managed to secure a +9.17% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.32M shares changing hands, 294.39K fewer than the previous session. This amounted to $11.31M in total market activity.
Will DNA Continue Its Upward Trend?
According to analyst ratings and projections for DNA, Ginkgo Bioworks Holdings, Inc. shares are anticipated to increase by +17.40%, potentially reaching $10.38 per share by May 26, 2026. Short-term technical indicators currently suggest a neutral sentiment for DNA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the DNA stock forecast, now is a good time to buy DNA stock because its current trading price is -11.06% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on DNA covering social and institutional perspectives.
DNA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into DNA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 48.67% to 52.60%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.44%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.14%, maintains a neutral outlook for the long term. Insights into DNA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Ginkgo Bioworks Short-Term Forecasts
DNA Forecast For Next 5 Days
Our algorithm anticipates Ginkgo Bioworks (DNA) stock could hit $9.17 by May 20, 2026. This represents a +6.96% fall from today's price, following a -5.54% change over the past five days.
DNA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Ginkgo Bioworks Holdings, Inc. (DNA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $8.45, which would mean a -1.40% decrease from the current price of $8.57. Projections for this period range from a high of $11.66 to a low of $5.63.
DNA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Ginkgo Bioworks's price over the next three months point to a rise. DNA stock is expected to peak at $16.24 on Jul 29, 2026 after potentially dipping to $7.49 on Jul 03, 2026. On average, DNA is likely to trade around $11.34 in the coming 90 days.
Ginkgo Bioworks Stock Forecast 2025
Based on our predictive models, Ginkgo Bioworks (DNA) is expected to trade between $2.98 and $16.24 throughout 2026. This would result in an average price of $10.36, potentially offering investors a +20.89% return from current levels.
Ginkgo Bioworks Holdings, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Ginkgo Bioworks Holdings, Inc. (DNA) is positioned to show a strong performance in May 2026. The price is predicted to move between $9.30 and $12.34, settling at an average of $11.01. This could translate to a +28.47% gain.
June 2026
Based on current market signals, Ginkgo Bioworks Holdings, Inc. is projected to trend june 2026. We forecast a trading range from $7.72 to $12.48, with a likely average price of $10.10. Investors could expect a potential return of +17.85%.
July 2026
Our predictive algorithms indicate Ginkgo Bioworks Holdings, Inc. stock may see a shift in July 2026. The expected range spans $7.49–$16.24, with an average target of $12.08. This represents a positive outlook and a possible gain of +40.96%.
August 2026
Analyzing established trends, Ginkgo Bioworks Holdings, Inc. looks set to move in August 2026. Projections place the stock between $9.57 and $15.43, averaging around $12.12. This suggests a +41.42% gain from current levels.
September 2026
Market indicators suggest Ginkgo Bioworks Holdings, Inc. could experience notable changes during September 2026. Prices could fluctuate within $8.89 to $13.78, with a midpoint forecast of $11.78. The stock might deliver a +37.46% gain.
October 2026
Forecasting for October 2026, models estimate that Ginkgo Bioworks Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $6.43 and $13.02, averaging $10.82. This signals a positive trajectory with potential returns around +26.25%.
November 2026
According to our latest forecast models, Ginkgo Bioworks Holdings, Inc. (DNA) is positioned to show a strong performance in November 2026. The price is predicted to move between $3.32 and $9.45, settling at an average of $7.04. This could translate to a -17.85% loss.
December 2026
Based on current market signals, Ginkgo Bioworks Holdings, Inc. is projected to trend december 2026. We forecast a trading range from $2.98 to $11.62, with a likely average price of $8.15. Investors could expect a potential return of -4.90%.
January 2027
Our predictive algorithms indicate Ginkgo Bioworks Holdings, Inc. stock may see a shift in January 2027. The expected range spans $2.33–$11.20, with an average target of $8.22. This represents a cautious outlook and a possible loss of -4.08%.
February 2027
Analyzing established trends, Ginkgo Bioworks Holdings, Inc. looks set to move in February 2027. Projections place the stock between $1.65 and $9.28, averaging around $8.28. This suggests a -3.38% loss from current levels.
March 2027
Market indicators suggest Ginkgo Bioworks Holdings, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $9.03, with a midpoint forecast of $8.34. The stock might deliver a -2.68% loss.
April 2027
Forecasting for April 2027, models estimate that Ginkgo Bioworks Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $7.25, averaging $5.81. This signals a cautious trajectory with potential returns around -32.21%.
May 2027
According to our latest forecast models, Ginkgo Bioworks Holdings, Inc. (DNA) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $6.25, settling at an average of $5.98. This could translate to a -30.22% loss.
DNA's history of dividends and stock splits also plays a role in long-term investor confidence.